For instance, patients with ulcerative colitis exhibit a reduction in endogenous levels of secondary BAs and that reconstitution of physiological levels of BAs by rectal administration of LCA mitigated murine colitis through a mechanism involving GPBAR1-dependent mitigation actions [51]. The gene discussed is GPBAR1; the disease is ulcerative colitis.